Primary tumor sites | 6Â months (%) | 12Â months (%) | 36Â months (%) |
---|---|---|---|
Unfavorable group | |||
 Esophagus | 61 | 49 | 49 |
 Hepatobiliary/pancreatic | 54 | 49 | 38 |
 colorectal | 85 | 43 | 21 |
Moderately unfavorable group | |||
 Kidney/ureter | 75 | 75 | 48 |
 Sarcoma/melanoma/mesothelioma | 84 | 84 | 28 |
Favorable group | |||
 Lung | 83 | 79 | 76 |
 Breast | 98 | 98 | 98 |
 Head and neck | 88 | 88 | 68 |
 Gynecological | 100 | 100 | 86 |
 Others | 94 | 86 | 86 |